| P50 | author | Fei Zhang | Q43088767 |
| P2093 | author name string | Yan Liu | |
| | Lei Yang | |
| | Ning Zhang | |
| | Hua Guo | |
| | Xiao-Fang Zhang | |
| | Li-Sha Qi | |
| P2860 | cites work | NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling | Q21296810 |
| | Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication | Q24290438 |
| | ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway | Q28506702 |
| | Cancer stem cells from colorectal cancer-derived cell lines. | Q30493732 |
| | Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations | Q33327492 |
| | Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells | Q33504768 |
| | Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA. | Q33651490 |
| | Colorectal cancer in Guangdong Province of China: a demographic and anatomic survey | Q33688323 |
| | A constitutive nucleolar protein identified as a member of the nucleoplasmin family. | Q33929283 |
| | The role of nucleophosmin in centrosome duplication | Q34526870 |
| | Knockdown of NPM1 by RNA interference inhibits cells proliferation and induces apoptosis in leukemic cell line | Q34893776 |
| | Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells | Q35842155 |
| | Nucleophosmin and cancer | Q36516405 |
| | Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. | Q36609847 |
| | Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation | Q36999887 |
| | Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. | Q37067488 |
| | Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. | Q37833502 |
| | Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma | Q37862650 |
| | Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer | Q37942733 |
| | Nucleophosmin delocalization in thyroid tumour cells | Q39603964 |
| | Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells | Q39616429 |
| | Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells | Q39705038 |
| | Playing both sides: nucleophosmin between tumor suppression and oncogenesis | Q39789241 |
| | Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation | Q39828468 |
| | Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1. | Q39845502 |
| | Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis | Q40090203 |
| | Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer. | Q40162937 |
| | Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells. | Q40252990 |
| | Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. | Q40275236 |
| | Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability | Q40282867 |
| | Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives | Q40606767 |
| | Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function | Q41036948 |
| | Nucleolin functions in the first step of ribosomal RNA processing. | Q42639990 |
| | Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts | Q42802019 |
| | Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs | Q42817619 |
| | Selection of cancer cells with repressed mitochondria triggers colon cancer progression | Q43191955 |
| | Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes | Q48164011 |
| | Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics. | Q51730708 |
| | Biological properties and expression of mucins in 5-fluorouracil resistant HT29 human colon cancer cells. | Q54048288 |
| | Nucleophosmin is overexpressed in thyroid tumors. | Q54671124 |
| | Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. | Q54696895 |
| | Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells | Q69002732 |
| | Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers | Q80339954 |
| | Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples | Q80769986 |
| | Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation | Q82846950 |
| | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone | Q83678537 |
| P921 | main subject | colon cancer | Q18555025 |
| | neoplastic invasiveness | Q112498967 |
| P304 | page(s) | 53 | |
| P577 | publication date | 2012-05-25 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Expression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells | |
| P478 | volume | 19 | |